Jill A. Howe
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jill A. Howe
Jill A. Howe is recorded as CFO and Board Member at Lineage Cell Therapeutics, Inc. (LCTX). Lineage Cell Therapeutics, Inc. reported in an 8-K filed October 31, 2022 that Jill A. Howe was appointed Chief Financial Officer, effective November 14, 2022.
“On October 28, 2022, Lineage Cell Therapeutics, Inc. ("Lineage," "we," "us," "our," or the "Company") appointed Jill A. Howe as its Chief Financial Officer, effective November 14, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-11-14–present
-
Current
2022-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lineage Cell Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian M. Culley CFO, Board Member
- Alexandra Hernandez Chief Accounting Officer
- Angus C. Russell Board Member
- Anula Jayasuriya Board Member
- Anula Jayasuriya, M.D., Ph.D., M.B.A. Board Member
- Brian Culley Board Member
- Deborah Andrews Board Member
- Dipti Amin Board Member
- Don Bailey Board Member
- Dr. Dipti Amin Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.